Electrophysiology

The FARAPULSE PFA System was purposefully built from the ground up to deliver PFA therapy and is optimized for patient safety and procedural ease, addressing many risks associated with traditional thermal cardiac ablation. The FARAPULSE system uses a novel, non-thermal, tissue-selective method for cardiac ablation that is fundamentally different from traditional modalities, which enables physicians to efficiently ablate cardiac tissue while minimizing procedural complications, such as impact to surrounding structures.^4,5

The proprietary puncture technology of the VersaCross RF Transseptal Solution enables safe and reliable left heart access to deliver critical cardiac therapies. By using RF energy instead of conventional mechanical needles, left heart access has become more predictable, with reduced rates of serious complications. The platform reimagines left heart access by reducing device exchanges during a procedure, while still using standard-of-care RF puncture technology.

The POLARx Cryoablation System is designed to provide greater physician control and increased procedural predictability during cardiac ablations. Combining a modernized console, balloon catheter, steerable sheath and circular mapping catheter, the POLARx System creates a direct path to pulmonary vein isolation while providing safe, efficient and effective treatment of atrial fibrillation.

OPAL HDx^TM Mapping System offers integrated mapping for both RF and pulsed field ablation procedures — while providing enhanced, leading-edge workflows with the FARAPULSE™ Pulsed Field Ablation System. 

Offering a complete range of mapping solutions, OPAL HDx allows you to choose the treatment modality that best meets your case needs.